Firms
Theme

DOC

Healthpeak Properties, Inc. · NYSE

News

2 latest

Zacks Investment Research

How to Find Strong Finance Stocks Slated for Positive Earnings Surprises

The article explains how to identify stocks poised for positive earnings surprises using the Zacks Earnings ESP (Expected Surprise Prediction) tool, which compares the most recent analyst estimates against consensus estimates. When combined with a Zacks Rank #3 or better, stocks with positive ESP have historically produced positive surprises 70% of the time with 28.3% average annual returns. Two finance stocks highlighted as examples are Healthpeak (DOC) and Victory Capital Holdings (VCTR), both with positive ESP figures ahead of their November earnings reports.

Zacks Investment Research

Why Investors Need to Take Advantage of These 2 Finance Stocks Now

The article explains the Zacks Earnings ESP (Expected Surprise Prediction) tool, which identifies stocks likely to beat quarterly earnings estimates by comparing the most recent analyst estimates against consensus estimates. When combined with a Zacks Rank of #3 or higher, stocks with positive ESP posted positive surprises 70% of the time with average annual returns of 28%. Two example stocks highlighted are Agree Realty (ADC) with +1.05% ESP and Healthpeak (DOC) with +2.33% ESP, both positioned to potentially beat upcoming earnings reports.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $DOC · 0 threads

Sign in to post on $DOC

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev